Global Blood Glucose Meters Pipeline Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

"Blood Glucose Meters Pipeline Report" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

This report offers extensive coverage of Blood Glucose Meters currently under development, encompassing a thorough examination of major pipeline products with detailed descriptions, licensing and collaboration details, and other pertinent developmental activities. It also delves into the major players actively engaged in the advancement of Blood Glucose Meters, shedding light on their respective pipeline projects and contributions to the industry.

The report categorizes these pipeline products based on their developmental stages, spanning from Early Development to Approved/Issued stages, providing insights into their progress and maturity. Furthermore, it supplies key clinical trial data related to ongoing trials specific to these pipeline products, allowing for an assessment of their current status and potential real-world applications.

Lastly, recent developments within the Blood Glucose Meter segment/industry are highlighted, encompassing the latest advancements, innovations, and trends shaping the landscape. This comprehensive report serves as a valuable resource for industry professionals, researchers, and stakeholders seeking insights into this field.

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Blood Glucose Meters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Blood Glucose Meters Overview

3 Products under Development

3.1 Blood Glucose Meters - Pipeline Products by Stage of Development

3.2 Blood Glucose Meters - Pipeline Products by Segment

3.3 Blood Glucose Meters - Pipeline Products by Territory

3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path

3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date

3.6 Blood Glucose Meters - Ongoing Clinical Trials

4 Blood Glucose Meters - Pipeline Products under Development by Companies

4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development

4.2 Blood Glucose Meters - Pipeline Products by Stage of Development

5 Blood Glucose Meters Companies and Product Overview

6 Blood Glucose Meters - Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

• 4a Medicom GmbH
• Abbott Diabetes Care Inc
• Abbott Healthcare Pvt Ltd
• Abbott Laboratories
• Actxa Pte Ltd
• Advanced Biosensors-Ohio LLC
• Advanced Medical Electronics Corp
• Afon Technology Ltd
• Alertgy Inc
• ALR Technologies Inc
• Arkal Medical Inc (Inactive)
• Azurite Technologies, Inc. (Inactive)
• Bar-Ilan University
• Baylor University
• Biofi Medical Healthcare Pvt Ltd
• BioGliko Sp zoo
• Biolinq Inc
• Biopeak Corp
• Biorasis Inc
• BioTex Inc
• Biovotion AG
• Brain Beat Ltd
• Brigham and Women's Hospital
• Brighter AB
• CALISTO MEDICAL, INC. (Inactive)
• Callitas Therapeutics Inc
• Cardiff University
• CGM3 Ltd
• Cirtec Medical Corp
• City, University of London
• Columbia University
• ConvaTec Group Plc
• Co-Optical Inc
• Cyber Medical Ltd (Inactive)
• DexCom Inc
• DiaMonTech GmbH
• DirectSens GmbH
• Echo Therapeutics Inc
• Ecole Polytechnique Federale de Lausanne
• eLutions Integrated Systems, Inc.
• Emperra GmbH E-Health Technologies
• EyeSense GmbH
• Firefly Health Pty Ltd
• Flowsion A/S
• Gili Medical Ltd
• Globe Medical Tech Inc (Inactive)
• GlucoLight Corporation (Inactive)
• GlucoMe Ltd
• Glucometrix AG
• GlucoModicum Oy
• Glucorecs
• GlucoRx Ltd
• Glucosat
• Glucosense Diagnostics Ltd (Inactive)
• GlucoSet AS
• GlucoStats System Pte Ltd.
• GlucoTrack Inc
• Glucovation Inc
• GluMetrics Inc
• Glusense Ltd
• GlySens Inc
• G-Sense Ltd.
• Guangzhou Powder Pharmaceuticals Ltd
• Guided Therapeutics Inc
• Hagar Tech
• Helo Corp
• iGlyko, Inc. (Inactive)
• Indigo Diabetes NV
• InLight Solutions Inc.
• Innopharmax Inc
• Innovosens AB
• Integrated Medical Sensors
• IntelliDx Inc (Inactive)
• InventHelp
• Invivomon Inc (Inactive)
• Invivosense ASA (Inactive)
• I-Sens Inc
• iSense Corporation (Inactive)
• Jiangsu Yuyue Medical Equipment & Supply Co Ltd
• KeenCAT Technologies
• Keratin Biosciences Inc
• Know Labs Inc
• KTH Royal Institute of Technology
• Lein Applied Diagnostics Limited
• LEMM Technologies, LLC
• Lifecare AS
• LifeScan Inc
• Light Touch Technology Co Ltd
• LighTouch Medical, Inc.
• Luminous Medical Inc (Inactive)
• Lyte Labs
• Massachusetts Institute of Technology
• Medical Wireless Sensing Ltd
• Medtronic MiniMed Inc
• Medtronic Plc
• Mellitor Ltd
• Metronom Health Inc
• MicroTech Medical Co Ltd
• mobiLIFE
• Mologic Ltd
• Movano Inc
• Nagasaki University
• Nemaura Medical Inc
• Newton Photonics Inc
• NIR Diagnostics Inc. (Inactive)
• Northwestern University
• Occuity Ltd
• Pelikan Technologies, Inc. (Inactive)
• Pepex Biomedical, Inc.
• PharmaTech Solutions Inc
• PKvitality SAS
• POPS! Diabetes Care Inc
• PositiveID Corp
• Profusa Inc
• Provigate Inc
• Purdue University
• Q Step Technologies, Inc.
• Quantum Operation Co Ltd
• Roche Diabetes Care Inc
• Sangui BioTech International Inc
• Sanmina Corp
• SD Biosensor Inc
• Senseonics Holdings Inc
• SensiVida Medical Technologies, Inc. (Inactive)
• Sensys Medical, Inc.
• Sentec Pte Ltd
• Shenzhen Refresh Biosensing Technology Co Ltd
• Shenzhen Sibionics Technology Co Ltd
• Shield Diagnostics
• Singapore Biomicro Pte Ltd
• Socrates Health Solutions, Inc.
• Solys Diagnostics Inc
• Spire Biophotonics Lifesciences
• St. Louis Medical Devices Inc (Inactive)
• Stony Brook University
• Swansea University
• Tandem Diabetes Care Inc
• TecMed Inc
• Tenax Therapeutics Inc
• Terumo Corp
• Texas A&M University
• Tonwo Health Clinic Technology Pty Ltd
• Ultradian Diagnostics LLC
• Umana Medical Technologies Ltd
• University of Bordeaux
• University of California Berkeley
• University of California Irvine
• University of California San Diego
• University of Central Florida
• University of South Carolina
• University of South Florida
• University of Technology Sydney
• University of Texas at Arlington
• Uxn Co Ltd
• VeriTeQ Corporation
• Virginia Commonwealth University
• VivaLyf Innovations Pvt Ltd
• Vytrace, Inc.
• Weglo
• Weitai Medical Equipment (Hangzhou) Co Ltd
• Xcellence in Bio Innovations & Technologies Pvt Ltd
• Zansors LLC
• Zyvex Corp

For more information about this report visit https://www.researchandmarkets.com/r/n85f29

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900